• Publications
  • Influence
Daylight photodynamic therapy for actinic keratosis: an international consensus
Photodynamic therapy (PDT) is an attractive therapy for non‐melanoma skin cancers including actinic keratoses (AKs) because it allows treatment of large areas; it has a high response rate and resultsExpand
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase III study
Daylight photodynamic therapy has shown good efficacy and safety results compared to conventional PDT in a recent Phase III multi‐centre randomised controlled trial in Australia among 100 subjects with AKs. Expand
Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases.
For patients with PCMZL who have multifocal lesions, chlorambucil therapy and radiotherapy are suitable therapeutic options and, in case of cutaneous relapses, the beneficial effects of treatment should be weighed against the potential adverse effects. Expand
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.
It is concluded that mature DC are superior to immature DC in the induction of immunological responses in melanoma patients, which may translate into improved clinical results. Expand
Novel and highly recurrent chromosomal alterations in Sézary syndrome.
The Sz genome is characterized by gross chromosomal instability with highly recurrent gains and losses, Prominent among deregulated genes are those encoding cMYC, cMYCs-regulating proteins, mediators of MYC-induced apoptosis, and IL-2 signaling pathway components. Expand
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology.
Imiquimod 5% cream used 3 times per week for 16 weeks is an effective treatment for AK, and clinical clearance was established by both clinical observation and histologic analysis. Expand
Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12.
It is reconfirms that narrow band UVB phototherapy is an effective treatment for vitiligo and shows that co-treatment with vitamin B12 and folic acid does not improve the outcome of treatment of Vitiligo with narrow bandUVBPhototherapy. Expand
Topical treatment of psoriatic plaques with 1,25‐dihydroxyvitamin D3: a cell biological study
The aim of the present study was to determine to what extent caicitriol (3 μ/g in white petrolatum) affects these parameters in vivo. Expand
Efficacy of blue light vs. red light in the treatment of psoriasis: a double‐blind, randomized comparative study
Protoporphyrin IX is present in psoriatic skin without the preceding application of aminolevulinic acid and is a potential target for photodynamic treatment with high‐dose visible light. Expand
Cutis marmorata telangiectatica congenita: report of 18 cases
Findings in 18 patients with cutis marmorata telangiectatica congenita who visited the University Hospital Nijmegen between 1982 and 1999 included hydrocephalus, hyperplasia/hypoplasia, anal atresia, hearing loss, cardiovascular abnormalities, strabismus hypothyroidism, haemangioma, naevus anaemicus, café‐au‐lait spot, lipoma and an elevation of the right diaphragm. Expand